180 related articles for article (PubMed ID: 8879730)
1. Influences on cost effectiveness.
Patel V
Br J Psychiatry; 1996 Sep; 169(3):381. PubMed ID: 8879730
[No Abstract] [Full Text] [Related]
2. One foot on the bandwagon?
Pies R
J Clin Psychopharmacol; 1995 Oct; 15(5):303-5. PubMed ID: 8830060
[No Abstract] [Full Text] [Related]
3. SSRIs versus tricyclics.
Rubinsztien JS; Michael A
Br J Psychiatry; 1996 Jul; 169(1):113-4. PubMed ID: 8818380
[No Abstract] [Full Text] [Related]
4. 'Number needed to treat'.
Gilbody S; Owens D
Br J Psychiatry; 1996 Jul; 169(1):113. PubMed ID: 8818379
[No Abstract] [Full Text] [Related]
5. Are SSRIs a cost-effective alternative to tricyclics?
Hotopf M; Lewis G; Normand C
Br J Psychiatry; 1996 Apr; 168(4):404-9. PubMed ID: 8730935
[TBL] [Abstract][Full Text] [Related]
6. Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression.
Crown WH
Acta Psychiatr Scand Suppl; 2000; 403():62-6. PubMed ID: 11019937
[TBL] [Abstract][Full Text] [Related]
7. TCAs or SSRIs as initial therapy for depression?
Tyra JM; Greenawald MH
J Fam Pract; 1999 Nov; 48(11):845-6. PubMed ID: 10907616
[No Abstract] [Full Text] [Related]
8. SSRIs vs tricyclic antidepressants.
Griffin GH
J Fam Pract; 1996 Feb; 42(2):110. PubMed ID: 8606296
[No Abstract] [Full Text] [Related]
9. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
[TBL] [Abstract][Full Text] [Related]
10. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
Anderson IM; Tomenson BM
BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of antidepressant treatment.
Head L; O'Keane V
Br J Psychiatry; 1997 Jul; 171():88. PubMed ID: 9328505
[No Abstract] [Full Text] [Related]
12. Cost-benefit analysis of newer versus older antidepressants--pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants.
Laux G
Pharmacopsychiatry; 2001 Jan; 34(1):1-5. PubMed ID: 11229615
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.
Kendrick T; Peveler R; Longworth L; Baldwin D; Moore M; Chatwin J; Thornett A; Goddard J; Campbell M; Smith H; Buxton M; Thompson C
Br J Psychiatry; 2006 Apr; 188():337-45. PubMed ID: 16582060
[TBL] [Abstract][Full Text] [Related]
14. The importance of accidents in evaluating the cost of SSRIs: a review.
Hale AS
Int Clin Psychopharmacol; 1994 Sep; 9(3):195-201. PubMed ID: 7814829
[TBL] [Abstract][Full Text] [Related]
15. Study addresses question of preferred initial therapy for depression.
Am J Health Syst Pharm; 1996 Sep; 53(17):1994. PubMed ID: 8870882
[No Abstract] [Full Text] [Related]
16. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant use among elderly patients.
Flint A; Silveira J
Am J Psychiatry; 2001 Feb; 158(2):328-30. PubMed ID: 11156834
[No Abstract] [Full Text] [Related]
18. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song F; Freemantle N; Sheldon TA; House A; Watson P; Long A; Mason J
BMJ; 1993 Mar; 306(6879):683-7. PubMed ID: 8471919
[TBL] [Abstract][Full Text] [Related]
19. TCAs vs SSRIs. Same bang for whose buck?
Gallo JJ
Arch Fam Med; 1999; 8(4):326-7. PubMed ID: 10418539
[No Abstract] [Full Text] [Related]
20. Pharmacological treatment of depression with and without headache disorders: an appraisal of cost effectiveness and cost utility of antidepressants.
Pan YJ; Kuo KH; Wang SJ
J Affect Disord; 2015 Jan; 170():255-65. PubMed ID: 25261631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]